TX
TherapeuticsMD, Inc.
TXMD · NASDAQ
$2.19 +0.23% (+$0.01)
1M +5.80%
Market Cap $25.3M
P/E Ratio -
Div. Yield -
ROE 0.80%
Piotroski F-Score Moderate
4/9Valuation
79 /100
Cheap P/B 0.93x
P/FCF 8.12x
P/S 7.75x
Growth
0 /100
Declining Book val. growth 8.55%
Rev. growth 64.91%
FCF growth N/A
Profitability
50 /100
Moderate Net margin 6.64%
Op. margin 118.20%
FCF margin 95.41%
Quality
2 /100
Poor ROE 0.80%
ROA 0.58%
Asset turnover 0.09x
Debt
69 /100
Low Current ratio 3.22x
Int. coverage -1,405.25x
Debt/Equity 0.20x
Stability
56 /100
Moderate Rev. volatility 89.38%
EPS volatility 10.76%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TXMD
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Marlan D. Walker
Employees
1
Headquarters
Boca Raton
Upcoming events
17 NOV
Earnings
Upcoming earnings report